The Future of Postoperative Pain: Trevena's Oliceridine. The world of medicine is constantly evolving, and one company at the forefront of this evolution is Trevena, Inc. (NASDAQ: $TRVN). A biopharmaceutical company with a focus on developing innovative therapies, Trevena recently made headlines with the publication of their research in the PLOS ONE journal. The study, titled "Efficacy, safety, and side effects of oliceridine in acu...
Stocksgoup : what news?
Greg Sarantopoulosスレ主 : Stock twits had some news that someone posted.
Greg Sarantopoulosスレ主 : check about 30 mins ago in Stocktwits